Codexis Inc.

+1.94 (+6.98%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.92B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$28.52 Million
Adjusted EPS-$0.09
See more estimates
10-Day MA$28.64
50-Day MA$26.12
200-Day MA$23.29
See more pivots

Codexis Inc. Stock, NASDAQ:CDXS

200 Penobscot Drive, Redwood City, California 94063-4718
Phone: +1.650.421.8100
Number of Employees: 181


Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.